Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses

Endocrinology

Volumn 148, Issue 2, 2007, Pages 752-761

  Martinez, Osvaldo ^c   Gangi, Eryn ^a   Mordi, David ^a   Gupta, Sonal ^a   Dorevitch, Samuel ^a   Lefranc, Marie Paule ^b   Prabhakar, Bellur S ^a,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b CNRS and University Montpellier II   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Building 935 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE ANTIBODY; OVALBUMIN; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVES DISEASE; HORMONE DETERMINATION; HUMORAL IMMUNITY; HYPERTHYROIDISM; IMMUNE RESPONSE; IMMUNIZATION; LIOTHYRONINE BLOOD LEVEL; MOUSE; MUTATION; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; THYROXINE BLOOD LEVEL;

ANIMALS; AUTOANTIBODIES; CELL LINE; COMPLEMENTARITY DETERMINING REGIONS; DISEASE PROGRESSION; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GRAVES DISEASE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULINS; MICE; POLYMERASE CHAIN REACTION; THYROTROPIN; THYROXINE; VARIATION (GENETICS);

EID: 33846458325     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1096     Document Type: Article

References (45)

1. Prabhakar BS, Fan JL, Seetharamaiah GS 1997 Thyrotropin-receptor- mediated diseases: a paradigm for receptor autoimmunity. Immunol Today 18:437-442
2. Kim WB, Chung HK, Park YJ, Park DJ, Lee HK, Cho BY 2001 Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies. Korean J Intern Med 16:187-200
3. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF 2002 A monoclonal thyroid-stimulating antibody. J Clin Invest 110:1667-1674
4. Costagliola S, Franssen JD, Bonomi M, Urizar E, Willnich M, Bergmann A, Vassart G 2002 Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochem Biophys Res Commun 299:891-896
5. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B 2002 Thyroid-stimulating monoclonal antibodies. Thyroid 12:1043-1050
6. Nordyke RA, Gilbert Jr FI, Miyamoto LA, Fleury KA 1993 The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 153:862-865
7. Costagliola S, Vassart G 2002 Monoclonal antibodies with thyroid stimulating activity, at last. Thyroid 12:1039-1041
8. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams Jr RC, Shine B, Marshall NJ 1990 Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86:723-727
9. MacNeil S, Munro DS, Metcalfe R, Cotterell S, Ruban L, Davies R, Weetman AP 1994 An investigation of the ability of TSH and Graves' immunoglobulin G to increase intracellular calcium in human thyroid cells, rat FRTL-5 thyroid cells and eukaryotic cells transfected with the human TSH receptor. J Endocrinol 143:527-540
10. McLachlan SM, Rapoport B 2004 Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward. Clin Endocrinol (Oxf) 61:10-18
11. Sanders J, Evans M, Premawardhana LD, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees Smith B 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362:126-128
12. Kabat EA, Wu TT, Reid-Miller M, Perry HM, Gottesman KS 1987 Sequences of proteins of immunological interest. Bethesda, MD: National Institutes of Health
13. Lefranc MP, Lefranc G 2001 The immunoglobulin factsbook. London: Academic Press
14. Ruiz M, Lefranc MP 2002 IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics 53:857-883
15. McIntosh R, Watson P, Weetman A 1998 Somatic hypermutation in autoimmune thyroid disease. Immunol Rev 162:219-231
16. Dogan RN, Vasu C, Holterman MJ, Prabhakar BS 2003 Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 170:2195-2204
17. Kaithamana S, Fan J, Osuga Y, Liang SG, Prabhakar BS 1999 Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol 163:5157-5164
18. Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 93:11074-11079
19. Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollman EF, Toccafondi RS, Kohn LD 1982 Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. Proc Natl Acad Sci USA 79:6680-6684
20. Kohn LD, Suzuki K, Hoffman WH, Tombaccini D, Marcocci C, Shimojo N, Watanabe Y, Amino N, Cho BY, Kohno Y, Hirai A, Tahara K 1997 Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 82:3998-4009
21. Shimojo N, Arima T, Yamaguchi K, Kikuoka S, Kohn LD, Kohno Y 2000 A novel mouse model of Graves' disease: implications for a role of aberrant MHC class II expression in its pathogenesis. Int Rev Immunol 19:619-631
22. Kikuoka S, Shimojo N, Yamaguchi KI, Watanabe Y, Hoshioka A, Hirai A, Saito Y, Tahara K, Kohn LD, Maruyama N, Kohno Y, Niimi H 1998 The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain. Endocrinology 139:1891-1898
23. Giudicelli V, Chaume D, Lefranc MP 2004 IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res 32:W435-W440
24. Lefranc MP, Giudicelli V, Kaas Q, Duprat E, Jabado-Michaloud J, Scaviner D, Ginestoux C, Clement O, Chaume D, Lefranc G 2005 IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 33:D593-D597
25. Monod MY, Giudicelli V, Chaume D, Lefranc MP 2004 IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 20(Suppl 1):I379 -I385
26. Underhill GH, Kolli KP, Kansas GS 2003 Complexity within the plasma cell compartment of mice deficient in both E- and P-selectin: implications for plasma cell differentiation. Blood 102:4076-4083
27. Waldmann TA, Strober W 1969 Metabolism of immunoglobulins. Prog Allergy 13:1-110
28. Slifka MK, Matloubian M, Ahmed R 1995 Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 69:1895-1902
29. Manz RA, Lohning M, Cassese G, Thiel A, Radbruch A 1998 Survival of long-lived plasma cells is independent of antigen. Int Immunol 10:1703-1711
30. McHeyzer-Williams MG 1997 Immune response decisions at the single cell level. Semin Immunol 9:219-227
31. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR, MacLennan IC 2000 Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med 192:813-821
32. Jack HM, Wabl M 1988 Immunoglobulin mRNA stability varies during B lymphocyte differentiation. EMBO J 7:1041-1046
33. Chen-Bettecken U, Wecker E, Schimpl A 1987 Transcriptional control of μ-and κ-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells. Immunobiology 174:162-176
34. Delassus S, Gey A, Darche S, Cumano A, Roth C, Kourilsky P 1995 PCR-based analysis of the murine immunoglobulin heavy-chain repertoire. J Immunol Methods 184:219-229
35. Dattamajumdar AK, Jacobson DP, Hood LE, Osman GE 1996 Rapid cloning of any rearranged mouse immunoglobulin variable genes. Immunogenetics 43:141-151
36. Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L, Thouvenin-Contet V, Lefranc G 2003 IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27:55-77
37. Gu H, Tarlinton D, Muller W, Rajewsky K, Forster I 1991 Most peripheral B cells in mice are ligand selected. J Exp Med 173:1357-1371
38. Haines BB, Angeles CV, Parmelee AP, McLean PA, Brodeur PH 2001 Germline diversity of the expressed BALB/c VhJ558 gene family. Mol Immunol 38:9-18
39. Dildrop R, Krawinkel U, Winter E, Rajewsky K 1985 VH-gene expression in murine lipopolysaccharide blasts distributes over the nine known VH-gene groups and may be random. Eur J Immunol 15:1154-1156
40. Freitas AA, Andrade L, Lembezat MP, Coutinho A 1990 Selection of VH gene repertoires: differentiating B cells of adult bone marrow mimic fetal development. Int Immunol 2:15-23
41. Costagliola S, Bonomi M, Morgenthaler NG, Van Durme J, Panneels V, Refetoff S, Vassart G 2004 Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18:3020-3034
42. Akkaraju S, Canaan K, Goodnow CC 1997 Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J Exp Med 186:2005-2012
43. Akkaraju S, Ho WY, Leong D, Canaan K, Davis MM, Goodnow CC 1997 A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7:255-271
44. Pichurin PN, Pichurina O, Marians RC, Chen CR, Davies TF, Rapoport B, McLachlan SM 2004 Thyrotropin receptor knockout mice: studies on immunological tolerance to a major thyroid autoantigen. Endocrinology 145:1294-1301
45. Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B 2002 Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209-217